Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion type Assertion NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_head.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion description "[Targeting of peptide epitopes may also be achieved using antibodies to MUC1 through induction of idiotypes and retrospective analyses in ovarian cancer have suggested a survival benefit for patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_provenance.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion evidence source_evidence_literature NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_provenance.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion SIO_000772 10341360 NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_provenance.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion wasDerivedFrom befree-20140225 NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_provenance.
- NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_assertion wasGeneratedBy ECO_0000203 NP453324.RA1ac7fY7eWcEcP49sGVN_dzjhykFC4BdfgGbdcPGT2A0130_provenance.